DCM Advisors’s Phibro Animal Health PAHC Stock Holding History

DCM Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,309	Closed	-$1.28M	–	315
2021 Q2	$1.28M	Buy	44,309 +19,309	+77%	+$522K	0.73%	43
2021 Q1	$610K	Buy	+25,000	New	+$565K	0.36%	96

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DCM Advisors's PAHC Position: Q3 2021 in Review

DCM Advisors sold out of Phibro Animal Health (PAHC) in Q3 2021, closing a stake of 44,309 shares — an estimated $1.28M sold.

DCM Advisors first reported a position in PAHC in Q1 2021 and held it in 2 quarters. The position peaked at $1.28M in Q2 2021. 142 funds tracked by Wall St. Rank hold PAHC as of Q3 2021.

DCM Advisors reported no remaining Phibro Animal Health position as of Q3 2021 after selling out during the quarter.
DCM Advisors sold 44,309 Phibro Animal Health shares in Q3 2021, an estimated $1.28M.
DCM Advisors first reported a position in Phibro Animal Health in Q1 2021 and held it in 2 quarters.
DCM Advisors's Phibro Animal Health position peaked at $1.28M in Q2 2021.
142 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2021.

Based on DCM Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.